E-CFC frequency in healthy blood donors and in patients with MPN grouped according to the diagnosis
. | Controls . | PV . | ET . | PMF . |
---|---|---|---|---|
CFU-EC, 106 cells, median (range) | 4.9 (0-42.5) | 0.75 (0-15.8) | 1.2 (0-6.5) | 0.7 (0-20.7) |
E-CFC, 107 cells, median (range) | 0.1 (0-0.8) | 0.1 (0-6.7) | 0 (0-9.6) | 0.8 (0-8) |
Samples with ≥ 1 E-CFC, n/N | 14/25 | 6/15 | 6/12 | 10/15 |
. | Controls . | PV . | ET . | PMF . |
---|---|---|---|---|
CFU-EC, 106 cells, median (range) | 4.9 (0-42.5) | 0.75 (0-15.8) | 1.2 (0-6.5) | 0.7 (0-20.7) |
E-CFC, 107 cells, median (range) | 0.1 (0-0.8) | 0.1 (0-6.7) | 0 (0-9.6) | 0.8 (0-8) |
Samples with ≥ 1 E-CFC, n/N | 14/25 | 6/15 | 6/12 | 10/15 |
Patients with PMF showed a higher E-CFC frequency than controls (P = .0078).